Monitoring literature and websites as part of pharmacovigilance.
Monitoring literature and websites as part of pharmacovigilance.
Monitoring scientific and medical literature and international websites
Monitoring literature and websites as part of pharmacovigilance.
A range of services for owners of reactor plants and pharmaceutical plants regarding pharmacovigilance:
Pharmacovigilance is a system of monitoring, control and regulation of the safety and effectiveness of medicines after their entry into the market and widespread use.
One important aspect of pharmacovigilance is the monitoring of literature and websites, which is necessary to promptly identify and respond to any signals of possible problems or side effects with the use of drugs.
Monitoring of scientific and medical literature and international websites is carried out by the Responsible Person for Pharmacovigilance of Adalan LLP at least once a week, in accordance with current legislation.
Description of the procedure
The responsible person receives information about the safety of medicinal products by the following methods:
- spontaneous messages,
- reports on clinical studies,
- monitoring messages from regulatory authorities,
- monitoring of local scientific, medical literature and websites of international and competent authorities
To obtain information from patients, medical workers and other applicants, Adalan LLP has organized telephone communication. Information about the telephone number and actual postal address of the company is posted in the instructions for medical use and on the packaging of the medicinal product, as well as in other information resources of the company.
The monitoring report is regularly submitted to NCELS and the Customer.
One important aspect of pharmacovigilance is the monitoring of literature and websites, which is necessary to promptly identify and respond to any signals of possible problems or side effects with the use of drugs.
Monitoring of scientific and medical literature and international websites is carried out by the Responsible Person for Pharmacovigilance of Adalan LLP at least once a week, in accordance with current legislation.
Description of the procedure
The responsible person receives information about the safety of medicinal products by the following methods:
- spontaneous messages,
- reports on clinical studies,
- monitoring messages from regulatory authorities,
- monitoring of local scientific, medical literature and websites of international and competent authorities
To obtain information from patients, medical workers and other applicants, Adalan LLP has organized telephone communication. Information about the telephone number and actual postal address of the company is posted in the instructions for medical use and on the packaging of the medicinal product, as well as in other information resources of the company.
The monitoring report is regularly submitted to NCELS and the Customer.
Benefits of monitoring literature and websites as part of pharmacovigilance
Quality
Our reputation is of great importance to us, and we are always focused on the successful completion of every project.
Support
Each member of our team has at least 5 years of experience in the pharmaceutical field.
Multidisciplinary
Our company is engaged in various fields of activity, in each of which we have achieved an outstanding professional level.
Experience
Over the course of 15 years, we have accumulated valuable experience in the field of registration and certification, we are aware of all the intricacies and take into account all the important aspects of this process.
Discount
We offer a 10% discount on initial registration.
Individual approach
We take into account the individual characteristics of each client to provide the best service and approach.
Our specialists will bring any project to the end, they will always tell you what strategy to choose and how to prepare the documents correctly!
Request a call back
Leave your contacts and we will call you back
By clicking the button, you consent to the processing of personal data and
agree to the privacy policy
agree to the privacy policy
Our services:
A full range of services to support the process of registration, re-registration, and changes to the registration dossier for medicines.
Comprehensive support for the process of registration, re-registration and updating of the registration dossier for medical devices and medical equipment in the Eurasian Economic Union (EAEU).
Providing comprehensive marketing services and representing the interests of the manufacturer at the regional level.
Providing a wide range of services for marketing authorization holders and pharmaceutical factories in the field of pharmacovigilance and product quality control.
Professional assistance in setting wholesale and retail prices for medicines and medical products within the framework of the guaranteed volume of free medical care.
A set of measures aimed at confirming the quality and safety of products.
Would you like to know the price for monitoring literature and websites as part of pharmacovigilance?
Leave a request and we will contact you
Our presence in other countries
We represent the interests of foreign companies in Kazakhstan, Belarus, Kyrgyzstan, Azerbaijan, Georgia, Armenia, Uzbekistan, Tajikistan, Mongolia and Turkmenistan, in other countries of the EAEU and the CIS.
| |
|
Contacts
050057, Republic of Kazakhstan,
Almaty, Timiryazev St., 42k23; office 202
Almaty, Timiryazev St., 42k23; office 202
© All rights reserved. Adalan LLP
Leave a request and get a free consultation
Leave your contacts
We do not transfer your data to third parties
Take the test and get a 10% discount on your first product registration
Enter your details and get a consultation
Leave your phone number and we will contact you!
Or call us at
+7 (727) 269 54 59